The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice. © 2014 Informa UK Ltd.

The minimum clinically important difference for EQ-5D index: A critical review / Coretti, S.; Ruggeri, M.; Mcnamee, P.. - In: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. - ISSN 1473-7167. - 14:2(2014), pp. 221-233. [10.1586/14737167.2014.894462]

The minimum clinically important difference for EQ-5D index: A critical review

Coretti S.;
2014

Abstract

The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is the most common instrument to value health outcomes under the patient's perspective. Several studies have investigated whether observed changes are meaningful to patients, using a variety of approaches to estimate the minimum clinically important difference (MCID). This study provides an overview of the state of art of the estimation of the MCID for the three-level EQ-5D index based on the UK scoring algorithm, critically assessing the available evidence. The interest in estimation of MCID for the EQ-5D has been increasing in recent years. However, some additional standardization in the estimation procedures may be of value, in order to enhance the ability to make comparisons across measures and disease areas. Further methodological research might also contribute to reducing gaps between theory and practice. © 2014 Informa UK Ltd.
2014
EQ-5D; Euro QoL; Minimum clinically important difference; Minimum relevant difference; Review; Smallest worthwhile effect; Europe; Humans; Quality of Life; Surveys and Questionnaires
01 Pubblicazione su rivista::01a Articolo in rivista
The minimum clinically important difference for EQ-5D index: A critical review / Coretti, S.; Ruggeri, M.; Mcnamee, P.. - In: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. - ISSN 1473-7167. - 14:2(2014), pp. 221-233. [10.1586/14737167.2014.894462]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1639542
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 64
  • Scopus 204
  • ???jsp.display-item.citation.isi??? 200
social impact